 |
For further MBL News and Media Information, contact the MBL Communications Office at (508) 289-7423 or e-mail us at comm@mbl.edu.
April 24, 2003
Marine Biological Laboratory Trustees Elect New Members
WOODS HOLE, MA—The Trustees of the Marine Biological Laboratory (MBL) elected three new Board members at their February 1, 2003 meeting. Richard B. DeWolfe of Milton, Massachusetts, William I. Huyett of Concord, Massachusetts, and Ambrose K. Monell of Palm Beach, Florida.
Founded in 1888, the MBL is a private, non-profit institution that serves as an international center for research, education, and training in biology, biomedicine, and environmental science. The MBL hosts many year-round laboratories in which scientists study cell and developmental biology, molecular evolution, neurobiology, ecology, global infectious diseases, and marine biotechnology and aquaculture. Each summer, 1,400 scientists and advanced students from around the world come to the MBL to participate in the Laboratory’s uniquely collaborative summer research program and highly competitive education program which plays a major role in training America's experimental biologists. Forty-eight Nobel Laureates have taught, taken courses, or done research at the MBL.
Richard B. DeWolfe is Managing Partner of DeWolfe & Company, LLC. He is a Director of John Hancock Financial Services Inc., The Boston Foundation, The National Conference for Community and Justice, and is also a Boston University Trustee. He was formerly Chairman and CEO of The DeWolfe Companies, Inc., the largest homeownership organization in New England, which was listed on the American Stock Exchange and acquired by Cendant Corporation in 2002. Mr. DeWolfe was formerly Chairman of Reliance Relocation Services, Inc. and former Chairman of the Board of Trustees at Boston University.
William I. Huyett is a Director at McKinsey and Company, Inc., and a leader in the firm’s pharmaceutical practice. He advises European and U.S.-based clients, who specialize in pharmaceuticals, over-the-counter, and medical devices. His areas of interest include innovation in pharmaceutical commercialization and marketing, novel corporate and organization forms for large pharmaceutical firms, the role of mergers and alliances in pharma industry evolution, and the comparative development of healthcare systems in Asia, Europe, and North America. Mr. Huyett also co-leads McKinsey’s strategy practice, which is responsible for innovation in the areas of business unit strategy, corporate strategy, and microeconomics. Currently based in Boston, he has served clients from McKinsey’s Zurich and Washington, D.C. offices. Prior to joining McKinsey, Mr. Huyett held a variety of line management positions in the electronics industry.
Ambrose K. Monell is a Director of the Ambrose Monell Foundation, founded in 1952 by Maude Monell Vetlesen. He is also a Director of the G. Unger Vetlesen Foundation founded in 1955 by the late George Unger Vetlesen. The Monell Foundation provided seed money for the Philadelphia-based Monell Chemical Senses Center founded in 1968. The G. Unger Vetlesen Foundation primarily supports scientific institutes and has a long history with the MBL. It has provided over $3.8 million since 1986, including significant gifts to the Laboratory’s Marine Resources Center, and Bay Paul Center. Mr. Monell has been a member of the MBL’s Council of Visitors since 1997.
|
